PWM
TCON

Perigon Wealth Management’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

Perigon Wealth Management’s Portfolio TCON Stock Details TCON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-2
Closed -$1K – 629
2018
Q1 		$1K Hold
2
– – ﹤0.01% 629
2017
Q4 		$1K Hold
2
– – ﹤0.01% 598
2017
Q3 		$1K Buy
+2
New +$1.04K ﹤0.01% 636

Other funds holding TCON

PCM
Puissance Capital Management New York $17.3M AUM 149.36% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
CWM
Cornerstone Wealth Management St. Peters, Missouri $2.33B AUM 25.21% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Perigon Wealth Management's TCON Position: Q2 2018 in Review

Perigon Wealth Management sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q2 2018, closing a stake of 2 shares — an estimated $1K sold.

Perigon Wealth Management first reported a position in TCON in Q3 2017 and held it in 3 quarters. The position peaked at $1K in Q1 2018. 34 funds tracked by Wall St. Rank hold TCON as of Q2 2018.

  • Perigon Wealth Management reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • Perigon Wealth Management sold 2 TRACON Pharmaceuticals, Inc. Common Stock shares in Q2 2018, an estimated $1K.
  • Perigon Wealth Management first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q3 2017 and held it in 3 quarters.
  • Perigon Wealth Management's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $1K in Q1 2018.
  • 34 funds tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q2 2018.

Based on Perigon Wealth Management's 13F filing for Q2 2018, filed 7 Aug 2018.